Henri Termeer, 71, former CEO of Genzyme
Henri Termeer of Marblehead, a leader in biotechnology and former CEO of Genzyme for nearly three decades, collapsed on Friday in his home, Sanofi Genzyme confirmed. He was 71 years old.
Mr. Termeer was born in the Netherlands.
He studied economics at the Economische Hogeschool, Erasmus University, the Netherlands, and earned an MBA from the Darden School at the University of Virginia.
He was appointed president of Genzyme in 1983 and served as CEO from 1985 until 2011, when the company was bought for more than $20 billion by French multinational pharmaceutical company Sanofi S.A.
Mr. Termeer was one of the founders at Lysosomal Therapeutics Inc. He also served as chairman emeritus and played an integral role in the founding of Network for Excellence in Health Innovation (NEHI). He served as chairman of the board of directors at AVEO Pharmaceuticals and the Federal Reserve Bank of Boston, and co-chair of the Leadership Council of the Massachusetts Life Sciences Collaborative.
He also served on the board for Abiomed Inc., Massachusetts Institute of Technology Corp., Partners HealthCare, Pharmaceutical Research and Manufacturers of America, Massachusetts General Hospital, and as a member of the board of fellows at Harvard Medical School. In 2008, he was appointed to Gov. Deval Patrick’s Council of Economic Advisors.
Funeral services for Mr. Termeer have not been determined.